Other disclosuresNSE · BLISSGVS
Bliss GVS Pharma Limited
Updates
01 / The disclosure
What the company shared
Bliss GVS Pharma Limited has informed the Exchange regarding 'Disclosure Submitted to Stock Exchanges on September 28, 2026 under Regulation 31A(10) of the SEBI Listing Regulations in relation to re-classification from the promoter and promoter group category to the public category. '.
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106817665
- First collected
- 14 Oct 2026, 18:53 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.